The startup develops a supply chain platform that utilizes artificial intelligence and machine learning to generate item-level demand forecasts for perishable goods in retail and wholesale environments. This technology enables clients to optimize inventory replenishment, reduce waste, and enhance profitability through precise data-driven insights.

AlphaSense provides an AI‑powered research platform that aggregates over 500 million premium documents—including expert transcripts, broker research, filings, and private data—into a single searchable index that also incorporates a user’s internal content. Its purpose‑built AI agents automate multi‑step workflows, extract key metrics, and generate fully cited analyses and real‑time alerts, enabling analysts, investors, consultants, and strategists to accelerate decision‑making while maintaining audit‑ready source traceability.

Anyword adds a performance‑prediction layer to generative AI copy workflows, using a model trained on millions of A/B test results to forecast which variant will achieve higher conversion. Its Data‑driven Editor ranks generated copy in real time, enforces centralized brand‑voice guidelines, and offers APIs and integrations for tools such as ChatGPT, Notion, and Gemini.

Aro Homes constructs carbon-negative residential buildings designed by Olson Kundig, utilizing precision engineering and smart energy technology to achieve 50% greater energy efficiency and low embodied carbon. The company addresses inefficiencies in traditional home construction by delivering high-quality, sustainable homes that save 11.2 tons of CO2 and 6,000 gallons of water annually.

Atom Computing develops gate-based quantum computers using arrays of optically-trapped neutral atoms, enabling the construction of scalable systems with over 1,000 error-corrected qubits. This technology addresses the need for high-performance quantum computing solutions that can support complex applications requiring long coherence times and optimized connectivity.

Augment is a context-aware Developer AI that integrates with your codebase, documentation, and dependencies to provide instant answers and personalized in-line code completions. It enables development teams to quickly navigate tasks, implement changes, and maintain productivity without interrupting their workflow.

BigHat Biosciences utilizes a machine learning-guided antibody design platform, Milliner, which integrates synthetic biology and high-speed wet lab processes to rapidly synthesize and characterize recombinant antibodies. The company focuses on developing safer and more effective antibody therapies for patients with challenging diseases, enhancing treatment options in the biopharmaceutical landscape.

BioLoomics develops monoclonal antibodies for targeted cancer therapies using specialized bioprocessing techniques to enhance therapeutic efficacy and specificity. The company provides treatment options that improve patient outcomes while minimizing adverse side effects in oncology.

Blue River Technology provides autonomous field robots that use high‑resolution vision and machine‑learning to detect weeds and apply variable‑rate herbicide only where needed, cutting chemical usage by up to 90 %. The robots navigate rows autonomously, process data on‑board, and upload treatment maps to a cloud platform that offers analytics, compliance reporting and API integration with farm‑management systems.

Provides an enterprise-focused video editing platform that transforms motion graphics from After Effects into reusable, responsive templates, enabling teams without design expertise to create branded videos quickly. By streamlining video production, Capsule reduces creation time by up to 90% compared to traditional tools, making it accessible for internal teams, marketing, and social media.

Character is a precision medicine company focused on macular degeneration and primary open-angle glaucoma, utilizing clinical genomic databases and machine learning to identify genetic drivers of disease progression. By characterizing patient subtypes, Character aims to develop targeted therapies for conditions that currently have limited treatment options.

Citrine Informatics accelerates materials and chemicals development with an AI-powered platform that unifies data and enables virtual experimentation. Its tools predict material properties and optimize product design, streamlining R&D and reducing time to market.

Claroty provides a cybersecurity platform that enhances visibility and protection for cyber-physical systems (CPS) across industrial, healthcare, and commercial sectors through asset inventory, exposure management, and continuous threat detection. The platform addresses vulnerabilities in interconnected operational technology and IoT environments, ensuring compliance with industry regulations and safeguarding critical infrastructure from cyber threats.

This startup offers a centralized platform for public health programs, streamlining healthcare logistics for testing, screening, treatment, and referrals. Their model aims to improve equitable healthcare delivery across entire populations by providing core capabilities to health programs and public health departments.

Provides a unified platform for building and deploying AI agents that integrate with enterprise systems to automate workflows, provide contextual assistance, and continuously optimize business operations. By mapping organizational knowledge and data to semantic models, these agents reduce manual tasks, improve decision-making, and enable real-time monitoring and adaptation across functions like sales, support, and engineering.

Datarails is a financial planning and analysis platform that integrates with Excel, allowing users to automate data consolidation, financial reporting, and budgeting processes. By leveraging AI, it provides real-time insights and scenario modeling, enabling finance teams to focus on strategic decision-making rather than manual data collection.

Dewpoint Therapeutics is developing a drug platform that targets biomolecular condensates, which are implicated in the dysregulation of complex diseases. By integrating AI with advanced experimental technologies, the company aims to create therapies for conditions previously considered undruggable.

Dosu offers an AI‑powered knowledge base platform that automatically generates and maintains documentation for engineering teams. By ingesting code repositories, issue trackers, and other technical artifacts, the system creates searchable, up‑to‑date docs and integrates with developers’ workflows via a CLI tool. The service is delivered as a subscription‑based SaaS, charging teams per user or per active project to streamline knowledge sharing and reduce manual documentation effort.

Eikon Therapeutics develops a proprietary single-molecule tracking platform that utilizes super-resolution microscopy to measure protein dynamics in living cells, enabling detailed analysis of molecular interactions. This technology addresses the challenge of understanding protein behavior, which is critical for identifying new drug targets and advancing therapeutic development for serious diseases.

ElectronX operates as a CFTC-regulated financial exchange and clearinghouse providing derivatives products focused on intraday power volatility. This platform enables energy market participants to execute precision risk management and volatility hedging strategies for electrical grid assets. The exchange supports energy producers, high-volume consumers, storage innovators, and market speculators navigating the evolving electricity supply chain.

Eppo provides an end-to-end experimentation platform that integrates feature flagging, statistical analysis, and personalization capabilities. The platform enables data teams, engineers, marketers, and product managers to run trustworthy, self-serve A/B tests and controlled rollouts. Its warehouse-native architecture ensures data governance and rigorous measurement against core business metrics without data egress.

Extend AI offers a spatial AI platform that generates real-time 3D digital twins and objective statistical models from live sensor data, enabling businesses to visualize and analyze their physical operations. This technology identifies inefficiencies and automates compliance verification, enhancing operational performance and decision-making.

Freenome provides a blood‑based early cancer detection platform that uses multiomics profiling—integrating genomics, epigenomics, proteomics, and metabolomics—with AI‑driven analysis to identify cancer at its most treatable stages. The minimally invasive test is designed for routine screening across multiple cancer types and is validated through ongoing clinical programs for use by healthcare providers.

Gatik provides Autonomous Transportation as a Service (ATaaS) utilizing proprietary Level 4 autonomous technology for B2B middle-mile logistics. Their solution operates on known, repeatable short-haul routes between distribution and retail locations to optimize regional supply chains. This integration enhances delivery reliability, reduces operational costs, and improves sustainability for customers.